| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
34,850,000 |
| Market
Cap: |
9.17(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1389 - $0.368 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with ulcerative colitis and related inflammatory indications. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
278,643 |
| Total Buy Value |
$0 |
$0 |
$0 |
$610,243 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
6 |
| Total Shares Sold |
0 |
599,209 |
1,097,868 |
1,140,781 |
| Total Sell Value |
$0 |
$97,534 |
$178,625 |
$257,300 |
| Total People Sold |
0 |
3 |
3 |
6 |
| Total Sell Transactions |
0 |
5 |
14 |
43 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Epq Llc, Amtc Ps |
owner |
– – – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,337,518) |
0 |
|
- |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(545,499) |
0 |
|
- |
|
| Hants Brandon |
CFO |
• – – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(301,225) |
0 |
|
- |
|
| Vandevender Aaron |
Director |
– • – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(212,659) |
0 |
|
- |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,600,000) |
0 |
|
- |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(484,738) |
0 |
|
- |
|
| Hants Brandon |
CFO |
• – – |
2023-11-22 |
4 |
S |
$0.16 |
$10,054 |
D/D |
(61,494) |
301,225 |
|
-66% |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-11-22 |
4 |
S |
$0.16 |
$46,785 |
D/D |
(286,320) |
484,738 |
|
-66% |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-11-22 |
4 |
S |
$0.16 |
$18,116 |
D/D |
(110,802) |
545,499 |
|
-66% |
|
| Hants Brandon |
CFO |
• – – |
2023-11-15 |
4 |
S |
$0.16 |
$8,053 |
D/D |
(50,146) |
362,719 |
|
-60% |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-11-15 |
4 |
S |
$0.16 |
$14,526 |
D/D |
(90,447) |
656,301 |
|
-60% |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-10-06 |
4 |
S |
$0.16 |
$30,378 |
D/D |
(184,442) |
771,058 |
|
-56% |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
886,111 |
955,500 |
|
- |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-09-29 |
4 |
S |
$0.16 |
$30,743 |
D/D |
(193,960) |
752,307 |
|
-68% |
|
| Hants Brandon |
CFO |
• – – |
2023-09-29 |
4 |
S |
$0.16 |
$17,045 |
D/D |
(107,540) |
415,786 |
|
-68% |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
886,111 |
946,267 |
|
- |
|
| Hants Brandon |
CFO |
• – – |
2023-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
491,111 |
523,326 |
|
- |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-09-05 |
4 |
S |
$0.21 |
$260 |
D/D |
(1,253) |
746,748 |
|
-11% |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-09-05 |
4 |
S |
$0.21 |
$466 |
D/D |
(2,245) |
69,389 |
|
-11% |
|
| Hants Brandon |
CFO |
• – – |
2023-09-05 |
4 |
S |
$0.21 |
$149 |
D/D |
(718) |
412,865 |
|
-11% |
|
| Cross Shawn |
CEO & Chair of the Board |
• • – |
2023-06-02 |
4 |
S |
$0.24 |
$1,038 |
D/D |
(4,306) |
748,001 |
|
39% |
|
| Mahmood Tahir Ph.d. |
Director |
– • – |
2023-06-02 |
4 |
S |
$0.24 |
$481 |
D/D |
(1,992) |
71,634 |
|
39% |
|
| Hants Brandon |
CFO |
• – – |
2023-06-02 |
4 |
S |
$0.24 |
$531 |
D/D |
(2,203) |
413,583 |
|
39% |
|
| Cross Shawn |
President & COO |
• – – |
2023-03-01 |
4 |
S |
$0.50 |
$467 |
D/D |
(934) |
60,156 |
|
45% |
|
| Hants Brandon |
CFO |
• – – |
2023-03-01 |
4 |
S |
$0.50 |
$252 |
D/D |
(504) |
32,315 |
|
45% |
|
106 Records found
|
|
Page 1 of 5 |
|
|
